0.00Open0.00Pre Close0 Volume0 Open Interest1.00Strike Price0.00Turnover744.61%IV-73.61%PremiumAug 16, 2024Expiry Date2.79Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9517Delta0.0135Gamma1.18Leverage Ratio-0.0150Theta0.0003Rho1.12Eff Leverage0.0010Vega
CureVac Stock Discussion
Benzinga· 1 min ago
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics.
First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent liti...
No comment yet